这是哈佛医学院生物化学和分子药理学系创建的网站。
This is the website maintained by Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School.
我们将会见证从传统的小分子药理学朝工程生物治疗的转变。
We will witness a shift from traditional small-molecule pharmacology towards engineered biological treatments.
这是谢菲尔德大学分子药理学和药物遗传学研究部的网站。
This is the website for Academic Unit of Molecular Pharmacology and Pharmacogenetics, the University of Sheffield.
这是一个经典模式。”哈弗大学医学院生化和分子药理学教授Struhl说道。
That's a classic pattern, " said Struhl, a professor of biological chemistry and molecular pharmacology at Harvard Medical School."
实验结果表明，这种方法在分子生物学以及分子药理学领域的研究工作中具有明显效果和广泛的应用价值。
The experimental results show that methods are quite satisfactory in the research work of molecular biology and molecular pharmacology.
该期刊由Elsevier公司出版，1995年与《欧洲药理学杂志：分子药理学》合并成为《欧洲药理学杂志》。
It is published by Elsevier and incorporated with European Journal of Pharmacology: Molecular Pharmacology into European Journal of Pharmacology in 1995.
在药理学里。受体更通常的是一个药物靶分子。
In pharmacology, a receptor is, more generically, any molecule that is a target for a drug.
为生物化学、分子生物学、药理学、免疫学等后续课程的学习奠定必要的有机化学基础。
This study will make necessarily foundation for the study of biochemistry, molecular biology, pharmacology and immunology and so forth.
分子识别的研究具有重要的生物学和药理学意义。
Molecular recognition is of central importance in biology and pharmacology.
水蛭素是特异的直接作用于凝血酶的抗凝剂。本文概述了其分子生物学特性、药理学特征、作用机理以及临床应用状况。
Hirudin is an anticoagulant directly acting on thrombin. Its molecular biological and pharmacological properties, mechanism of action, current clinical researches and USES were reviewed.
基础医学研究的前沿学科是：生物信息学及其带动的医学分子生物学、遗传学、免疫学、内分泌学、药理学和神经科学等。
The frontier in the basic medicine are: bioinformatics and it will induce the medical molecular biology, genetics, immunology, endocrinology, pharmacology, neurology, etc.
阿兹海莫症：以分子生物学领域的了解预测以类淀粉胜肽为基础的治疗〉《药理学与毒物学研究回顾杂志》43（2003）： 545-84。
Selkoe, D. J. , and D. Schenk. "Alzheimer's Disease: Molecular Understanding predicts Amyloid-based Therapeutics. " Annu Rev Pharmacol Toxicol. 43(2003): 545-84.
职位职责：1．硕士学历，分子生物学、细胞生物学、基础医学、药理学等相关专业；肿瘤领域研究背景；
Minimum requirements: The candidate is expected has master in Biochemistry, Molecular Biology, Cell Biology, Pharmacology or related field and have cancer relevant research experience.
本发明提供了增强MC4R活性的MC4R药理学陪伴分子。
The invention provides MC4R pharmacological chaperones which enhance the activity of MC4R.
本发明提供了增强MC4R活性的MC4R药理学陪伴分子。
The invention provides MC4R pharmacological chaperones which enhance the activity of MC4R.
应用推荐